The global glucose monitoring devices market was valued at USD 14.1 billion in 2023 and is expected to grow to USD 15.67 ...

Abbott NORTHAMPTON, MA / ACCESS Newswire / February 10, 2025 / Four out of 10 people living with diabetes miss appointments due to shame1. How can we change that?A lot of things we commonly hear about ...

The Food and Drug Administration Feb. 5 released an alert notifying patients of a safety concern using diabetes devices such ...

The FreeStyle Libre 3 system helped Nathan manage his diabetes. Now, he's sharing his story to help lift stigma.Abbott NORTHAMPTON, MA / ACCESS Newswire / February 7, 2025 / As a competitive powerlift ...

Health-related technologies have evolved significantly in the modern world, offering people innovative tools to manage their ...

Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...

Abbott (NYSE:ABT) today unveiled a new initiative addressing the biases and stigmas associated with diabetes management.

One cupcake won't kill you,' 'I'm going to get diabetes just looking at that,' 'That person doesn't look like they ...

Daewoong Pharmaceutical launches thynC remote patient monitoring with insurance coverage Innovative remote monitoring system ...

Medical device and healthcare company Abbott has opened a new facility in Kilkenny, which is expected to employ 800 people.

In this interview, we spoke with Tia about the importance of metabolic monitoring in CGT research, how continuous monitoring can overcome ... LiCellMo is an instrument that measures glucose and ...